Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 11/20 | 0.35 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.34 |
| ▸ | LIPE | Q05469 | 4/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | MLYCD | O95822 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21678309 | 0.86 | LIPE (0.34) | SCN9ANR1H2LIPELMNAMAPT | |
| SCHEMBL18529452 | 0.82 | LIPE (0.43) | LIPELMNAKDM4E | |
| SCHEMBL21678318 | 0.81 | SCN9A (0.33) | SCN9ALIPE | |
| SCHEMBL21703278 | 0.80 | ALDH1A1 (0.36) | SCN9ALIPELMNAKDM4EMAPT | |
| SCHEMBL20031600 | 0.77 | SCN9A (0.41) | SCN9AGPR119KDM4EMAPTL3MBTL1 | |
| SCHEMBL21678314 | 0.74 | PDE4D (0.37) | SCN9ALMNA | |
| SCHEMBL18529451 | 0.69 | XPO1 (0.47) | MLYCD | |
| SCHEMBL6232464 | 0.67 | NPC1 (0.38) | LMNAKDM4EMAPT | |
| SCHEMBL19994245 | 0.67 | PKM (0.43) | LIPEMAPTL3MBTL1 | |
| SCHEMBL18529453 | 0.66 | LIPE (0.44) | LIPELMNAKDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200045967-A1 | NOVEL TRIAZOLE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-02-13 | — | — | US | disclosed |
| US-20200045967-A1 | NOVEL TRIAZOLE DERIVATIVES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200045967-A1 | NOVEL TRIAZOLE DERIVATIVES | CYP51A1, ERG28, SBK3 | SCN9A 4735/4885NR1H2 2756/4885LIPE 1706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.